SCHEMBL8224262

SCHEMBL8224262

C=CCN(CC=C)c1ccc(C)cn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 2/20 0.39
CCR1 P32246 1/20 0.39
CCR5 P51681 1/20 0.39
CCR8 P51685 1/20 0.39
GBA1 P04062 1/20 0.38
NOS3 P29474 1/20 0.36
NOS2 P35228 1/20 0.36
C5AR1 P21730 1/20 0.34
CRHR1 P34998 3/20 0.33
HCAR3 P49019 1/20 0.33
CHKA P35790 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC2 Q92769 1/20 0.32
HDAC9 Q9UKV0 1/20 0.32
CNR1 P21554 1/20 0.31
CNR2 P34972 1/20 0.31
ADRA2A P08913 3/20 0.31
ADRA2B P18089 3/20 0.31
ADRA2C P18825 3/20 0.31
PLAU P00749 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7228035 0.78 GBA1 (0.59) GBA1CHKAMAPTRAB9ASMN1; SMN2
SCHEMBL179288 0.76 GBA1 (0.62) HDAC6CCR1CCR5CCR8GBA1
SCHEMBL20056973 0.73 HCAR3 (0.57) HDAC6CCR1CCR5CCR8GBA1
SCHEMBL7242158 0.71 CCR1 (0.43) HDAC6CCR1CCR5CCR8NOS3
SCHEMBL23183031 0.70 GBA1 (0.50) HDAC6CCR1CCR5CCR8GBA1
SCHEMBL12394221 0.70 HCAR3 (0.46) HDAC6CCR1CCR5CCR8GBA1
SCHEMBL21388440 0.70 HCAR3 (0.50) HDAC6CCR1CCR5CCR8GBA1
SCHEMBL544100 0.70 ALDH1A1 (0.48) C5AR1CRHR1CHKACNR1CNR2
SCHEMBL175241 0.69 CHRM2 (0.44) ADRA2AADRA2BADRA2CMAPTRAB9A
SCHEMBL21241060 0.69 GBA1 (0.45) HDAC6CCR1CCR5CCR8GBA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0569701-B1 Process for preparation of 2-amino-5-methyl-pyridine BAYER AG (DE) 2000-09-27 EP claimed
US-5463065-A Process for the preparation of 2-amino-5-methyl-pyridine BAYER AKTIENGESELLSCHAFT (DE) 1995-10-31 US claimed
US-5332824-A Process for the preparation of 2-amino-5-methyl-pyridine BAYER AKTIENGESELLSCHAFT (DE) 1994-07-26 US claimed
EP-0569701-A1 Process for preparation of 2-amino-5-methyl-pyridine BAYER AG (DE) 1993-11-18 EP claimed
EP-0569701-B1 Process for preparation of 2-amino-5-methyl-pyridine BAYER AG (DE) 2000-09-27 EP disclosed
US-5463065-A Process for the preparation of 2-amino-5-methyl-pyridine BAYER AKTIENGESELLSCHAFT (DE) 1995-10-31 US disclosed
US-5463065-A Process for the preparation of 2-amino-5-methyl-pyridine BAYER AKTIENGESELLSCHAFT (DE) 1995-10-31 US disclosed
US-5332824-A Process for the preparation of 2-amino-5-methyl-pyridine BAYER AKTIENGESELLSCHAFT (DE) 1994-07-26 US disclosed
EP-0569701-A1 Process for preparation of 2-amino-5-methyl-pyridine BAYER AG (DE) 1993-11-18 EP disclosed
EP-0569701-A1 Process for preparation of 2-amino-5-methyl-pyridine BAYER AG (DE) 1993-11-18 EP disclosed